NEWS

News Articles

BIOPHARMA LEADERS UNITE TO STAND WITH SCIENCE

September 8, 2020

Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines NEW YORK – September 8, 2020 – The CEOs of AstraZeneca, BioNTech, GlaxoSmithKline plc, Johnson & Johnson, Merck, known as MSD outside the United States and Canada, Moderna, Inc., Novavax,…

Read More

Morehouse School of Medicine to get $26 million from Bloomberg Philanthropies

September 3, 2020

Morehouse School of Medicine will receive a financial shot in the arm that could reduce a major side effect of earning a medical degree: loan debt. Bloomberg Philanthropies is giving the historically Black medical school $26 million. The funding goes to currently enrolled students who receive financial aid. Each eligible student will get about $100,000. “This…

Read More

Biotech Leaders Outline Principles to Ensure the “Public’s Trust” in New Medical Products for Eradicating Covid-19

September 3, 2020

As America’s researchers race to develop the scientific solutions needed to eradicate Covid-19, leaders within the Biotechnology Innovation Organization (BIO) released an open letter to their biopharmaceutical colleagues that articulates key principles to ensure the “integrity, transparency, and objective assessment” of Covid-19 clinical data and secure public trust in new medical products developed in response to the…

Read More

Georgia students seek degrees in growing industries

September 3, 2020

As the shifting business landscape changes the demand for trained workers in many industries in Georgia, students at colleges and universities across the state are gravitating toward degree programs that will equip them to fill the jobs of the future. The largest number of degrees earned by students of schools within the University System of…

Read More

CryoLife announces acquisition of aortic repair device developer

September 2, 2020

CryoLife (NYSE:CRY) acquires Florida-based Ascyrus Medical for up to $200M, including $60M cash and $20M shares of CryoLife’s common stock in upfront payment. Ascyrus is a privately-held developer of the Ascyrus Medical Dissection Stent (AMDS), the world’s first aortic arch remodeling device used for the treatment of acute Type A aortic dissections.  The acquisition will result in CryoLife’s high single-digit revenue growth beginning in…

Read More

Sherry Farrugia Named GCMI Interim CEO

September 1, 2020

Global Center of Medical Innovation’s Board of Directors has announced Sherry Farrugia will serve as the organization’s interim CEO, effective immediately. Ms. Farrugia comes to GCMI from the Children’s Healthcare of Atlanta, Pediatric Technology Center at the Georgia Institute of Technology, where she was Chief Operating and Strategy Officer spending the past 10 years focused…

Read More